GlassScriptPhysician profile
Abigail R Prest
NPI 1083000731
$1,873.73
in general payments reported to CMS, 2019-2025
24 companies · $17.82 in 2025
The $17.82 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $322 · 2021: $255 · 2022: $377 · 2023: $458 · 2024: $194 · 2025: $17.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $572.99 | 2019-2023 | |
| Astellas Pharma US INC | $161.62 | 2022-2024 | Veozah, Myrbetriq |
| Organon LLC | $156.22 | 2021-2024 | Jada System, Nexplanon |
| Hologic Sales and Service, LLC | $120.64 | 2020-2025 | Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $120.49 | 2019-2023 | |
| Evofem Biosciences, INC. | $100.75 | 2021-2022 | |
| Exeltis, USA INC. | $96.74 | 2020-2024 | Slynd |
| Exact Sciences Corporation | $48.85 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $47.96 | 2024 | |
| Sumitomo Pharma America, INC. | $46.55 | 2023 | Myfembree, Gemtesa |
| Pfizer INC. | $41.41 | 2022-2024 | |
| Coopersurgical, INC. | $40.02 | 2022-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $39.01 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $38.18 | 2020-2021 | |
| Axonics, INC. | $36.42 | 2022-2023 | Bulkamid |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $33.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $31.16 | 2022 | |
| Amag Pharmaceuticals, INC. | $27.24 | 2019 | |
| Davol INC. | $23.94 | 2023 | Arista Ah Flexitip |
| Ethicon US, LLC | $20.19 | 2023 | Surgicel Nu-Knit |
| Daiichi Sankyo INC. | $20.01 | 2024 | Injectafer |
| Agile Therapeutics, INC. | $17.42 | 2021 | |
| Intuitive Surgical, INC. | $16.60 | 2019 | |
| Minerva Surgical, INC | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Prest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.